BioCentury
ARTICLE | Clinical News

Centanafadine SR: Phase IIb data

August 1, 2016 7:00 AM UTC

A double-blind, crossover, U.S. Phase IIb trial in 85 adults with ADHD showed that twice-daily 400 mg oral centanafadine SR met the primary endpoint of improving ADHD-RS-IV total score from baseline t...